Canopy Growth Corp.
- CGC · Nasdaq
- Medicinal Chemicals & Botanical Products
- Smith Falls, A6
- 1,128 employees
- CIK 0001737927
Updated from SEC filings through
Top things to know
Executives
-
Luc Mongeau Chief Executive Officer Form 4, June 22, 2026 -
Christelle Gedeon Chief Business Development & Corporate Affairs Officer 10-K, June 15, 2026 - Thomas Stewart CFO DEF 14A, August 7, 2026
Canopy Growth Corp is a U.S. public company in medicinal chemicals & botanical products (SIC 2833), headquartered in Smith Falls, A6. It trades as CGC on Nasdaq. It reported about 1,128 employees. Luc Mongeau is Chief Executive Officer.
Five-year financials
We have no annual financials for this company yet.
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| C-Suite Leader | Transformational Leadership | | Chief Executive Officer | Form 4, June 22, 2026 |
| Thomas Stewart | Named in proxy bio: CFO | DEF 14A, August 7, 2026 |
| | Chief Business Development & Corporate Affairs Officer | 10-K, June 15, 2026 |
| M. Shan Atkins | Board member (per proxy) bio: Director | DEF 14A, August 7, 2026 |
What Canopy Growth Corp does
Committed to Bettering Lives Through Cannabis For the patient finding relief, the person rediscovering balance, the consumer who expects better.
Company website description, 10-K for the year ending November 7, 2026
Shares and governance
| Shares outstanding | 423.4 million (as of November 4, 2026) | 10-Q, November 6, 2026 |
|---|---|---|
| Public float | $485M (as of September 30, 2025) | 10-K, June 15, 2026 |
| Reportable segments | 2 (period ending September 30, 2026) | 10-Q, November 6, 2026 |
| Latest proxy statement | Meeting September 25, 2026 (filed August 7, 2026) | DEF 14A, August 7, 2026 |
| Auditor | PKF O’Connor Davies, LLP (New York, New York) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| September 28, 2026 | Theresa Yanofsky Director | Sale | 14,920 | $14K | Form 4, September 30, 2026 |
| September 28, 2026 | David Angelo Lazzarato Director | Sale | 22,380 | $21K | Form 4, September 30, 2026 |
| September 28, 2026 | Joseph Bayern Director | Sale | 3,096 | $3K | Form 4, September 30, 2026 |
| September 28, 2026 | M. Shan Atkins Director | Sale | 3,096 | $3K | Form 4, September 30, 2026 |
| September 17, 2026 | Thomas Carlton Stewart See Remarks | Sale | 25,755 | $24K | Form 4, September 17, 2026 |
| August 24, 2026 | Christelle Gedeon See Remarks | Sale | 13,344 | $20K | Form 4, August 25, 2026 |
| August 24, 2026 | Thomas Carlton Stewart See Remarks | Sale | 2,231 | $3K | Form 4, August 25, 2026 |
| June 26, 2026 | Joseph Bayern Director | Sale | 3,197 | $3K | Form 4, June 29, 2026 |
Recent 8-K events
- 8-K filed 2026-11-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-23
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-10-16
- Item 3.01 Notice of delisting or failure to meet listing standards
- 8-K filed 2026-08-07
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-08-07
- Item 4.01 Changes in registrant's certifying accountant
- 8-K filed 2026-06-15
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-05-27
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- 8-K filed 2026-05-15
- Item 4.02 Non-reliance on previously issued financial statements
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-03-16
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
- 8-K filed 2026-02-06
- Item 2.02 Results of operations and financial condition (earnings release)
Frequently asked questions about Canopy Growth Corp
- What does Canopy Growth Corp do?
- In its own words, from Item 1 of its 10-K: "Committed to Bettering Lives Through Cannabis For the patient finding relief, the person rediscovering balance, the consumer who expects better."
- How many employees does Canopy Growth Corp have?
- About 1,128 as of March 31, 2026, as stated in its annual report.
- Who is the CEO of Canopy Growth Corp?
- Luc Mongeau, Chief Executive Officer, as named in a 4 filed June 22, 2026.
- Where is Canopy Growth Corp headquartered?
- Smith Falls, A6.
- What is Canopy Growth Corp's stock ticker?
- CGC on Nasdaq.
- What industry is Canopy Growth Corp in?
- Medicinal Chemicals & Botanical Products, SIC code 2833.
- What is Canopy Growth Corp's website?
- canopygrowth.com.
- When does Canopy Growth Corp report earnings next?
- February 5, 2027. This is an estimate from past filing dates, not a confirmed date.
- Is Canopy Growth Corp a public company?
- Yes. Canopy Growth Corp files with the SEC under CIK 0001737927 and trades as CGC.
- Who audits Canopy Growth Corp?
- PKF O’Connor Davies, LLP, New York, New York, as named in its latest annual report (10-K).
- How many shares of Canopy Growth Corp are outstanding?
- 423.4 million shares as of November 4, 2026, from its 10-Q filed November 6, 2026.
- What is Canopy Growth Corp's public float?
- $485M as of September 30, 2025, as reported on the cover of its 10-K filed June 15, 2026.
- How many business segments does Canopy Growth Corp report?
- 2 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 6, 2026.
- When is Canopy Growth Corp's annual shareholder meeting?
- September 25, 2026, per its proxy statement (DEF 14A) filed August 7, 2026.
- Have Canopy Growth Corp insiders traded stock recently?
- Since June 30, 2025, officers and directors reported 31 open-market sales worth about $548K and 1 purchase worth about $50K on Forms 4 and 5. The most recent: Theresa Yanofsky (Director) sold 14,920 shares on September 28, 2026.